Sharp Therapeutics Corp.
SHRX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | 1,389.82% | -37.94% | 0.00% | 0.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -15.31% | -- | -- | 0.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 0.00% | 1,057.95% | -- | -- | 0.00% |
|
|
|||||
| Total Current Assets | 0.00% | 1,057.95% | -- | -- | 0.00% |
| Net Property, Plant & Equipment | 0.00% | -4.66% | -- | -- | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -- | -- | 0.00% |
| Total Assets | 0.00% | 227.93% | -- | -- | 0.00% |
|
|
|||||
| Total Accounts Payable | 0.00% | -36.95% | -- | -- | 0.00% |
| Total Accrued Expenses | 0.00% | -41.19% | -- | -- | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 16.77% | -- | -- | 0.00% |
| Total Finance Division Other Current Liabilities | 0.00% | 692.12% | -- | -- | -- |
| Total Other Current Liabilities | 0.00% | 692.12% | -- | -- | -- |
| Total Current Liabilities | 0.00% | -95.28% | -- | -- | 0.00% |
|
|
|||||
| Total Current Liabilities | 0.00% | -95.28% | -- | -- | 0.00% |
| Long-Term Debt | -- | -- | -- | -- | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | -1.55% | -- | -- | 0.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | 0.00% | -87.62% | -- | -- | 0.00% |
|
|
|||||
| Common Stock & APIC | 0.00% | 336.44% | -- | -- | 0.00% |
| Retained Earnings | 0.00% | -1.15% | -- | -- | 0.00% |
| Treasury Stock & Other | 0.00% | -- | -- | -- | -- |
| Total Common Equity | 0.00% | 117.81% | -26.39% | 0.00% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.00% | 117.81% | -26.39% | 0.00% | 0.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | 117.81% | -26.39% | 0.00% | 0.00% |
|
|
|||||